Glycemic Management Blueprint: How NY-Based Hospital Systems Act as a Microcosm for Glycemic Safety

Why It Matters

Mandated glycemic metrics transform patient safety into a reimbursable, reputation‑driving priority, compelling hospitals to adopt automated insulin‑management solutions.

Key Takeaways

• CMS will mandate glycemic ECQMs starting FY2026, affecting reimbursement
• Severe hypoglycemia metrics focus on <40 mg/dL and >300 patient‑days
• Hospital staff face manual documentation burdens; automation can reduce burnout
• Alignment of CMS, Joint Commission, VA, and IHS signals nationwide focus
• Integrated EMR tools like Glidec improve insulin dosing accuracy and safety

Summary

The webinar framed New York hospital systems as a microcosm for the nation’s evolving glycemic safety agenda. Speakers highlighted the federal push—CMS’s upcoming mandatory ECQMs for severe hypoglycemia beginning FY2026, with reimbursement penalties slated for FY2028—and the parallel requirements from the Joint Commission, Veterans Affairs, and Indian Health Services. Key data points underscored the urgency: hypoglycemia ranks among the top five adverse drug events for Medicare patients, while over 30% of non‑critical inpatients experience hyperglycemia. The two new metrics—episodes below 40 mg/dL and cumulative patient‑days above 300 after the first 24 hours—serve as flagsticks for preventable and treatable events, respectively. Financial and reputational stakes were emphasized, as public reporting will influence consumer choice and health‑system competition. Panelists illustrated real‑world challenges. Ashley cited the OIG study on adverse events; Jordan noted that physicians adjust long‑acting insulin doses in only 15‑20% of low‑glucose cases, a clear missed opportunity. Kendra described how manual insulin calculations and outdated sliding‑scale protocols increase cognitive load, while technology—EMR‑embedded decision support and platforms like Glidec—can automate dosing and reduce human‑factor errors. The consensus was clear: hospitals must move beyond checkbox compliance to integrated, data‑driven insulin management. Deploying automated tools can lower staff burnout, improve safety metrics, and protect revenue streams, positioning institutions as leaders in a landscape where glycemic control is now a core quality indicator.

Original Description

A live fireside chat featuring healthcare experts from across New York state, exploring how one of the country's most complex hospital markets serves as a blueprint for glycemic management excellence everywhere.

Expect a candid, expert-led conversation across three perspectives:

- Clinical — Best practices and common gaps at the point of care

- Operational — Building workflows that sustain glycemic safety at scale

- Policy — How mandates and quality benchmarks are raising the stakes

Whether you lead a clinical program, manage quality initiatives, or set strategy for your health system, this discussion is built for you.

------------------------------------------------------------------------------------------------------------------------

This webinar is a program of the Partners Advisory Committee and is hosted by Glytec. Leapfrog Group does not endorse the products, services, and/or technology showcased on this webinar, however we encourage you to explore these offerings from a Leapfrog supporter.